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Abstract 
We present a case of small bowel diverticulum with gastrointestinal stromal tumor 
(GIST). This GIST in the diverticulum was confirmed by immunohistochemistry and was of 
low-grade malignant potential. 
 
Case Report 
A 22-year-old woman presented to our department with a history of upper gastrointestinal (GI) 
bleed in the form of melena of recent onset. She was initially evaluated with upper GI endoscopy and no 
cause was found. Subsequently, she was subjected to lower GI endoscopy with distal ileal inspection; 
findings were again normal. Since no cause for the GI bleed was found and due to ongoing minor GI 
bleed in the form of melena, a repeat upper and lower GI endoscopy was performed by the senior-most 
endoscopist of the institute, which was again inconclusive. The patient was diagnosed with obscure GI 
bleed and a CT enteroclysis was planned. A 64-slice CT enteroclysis showed a lesion in relation to the 
mid small bowel loop, which was highly vascular (fig. 1). A tentative diagnosis of small bowel 
gastrointestinal stromal tumor (GIST) possibly in a diverticulum was made. The patient was subjected 
to laparotomy and the extremely rare finding of a mass lesion in a small bowel diverticulum in the distal 
few centimeters of the jejunum was made. This tumor had a size of 4 × 4 cm, was highly vascular and 
located in an antimesenteric diverticulum (fig. 2). 
The patient underwent resection of the small bowel with 10-cm margins on either side, along with 
which a reasonable amount of mesentery was excised (fig. 3). The mucosal surface of resected jejunum 
inspected showed the mouth of the diverticulum (fig. 4). Histopathological examination of the 
specimen was suggestive of GIST (fig. 5) in a diverticulum, which was confirmed by electron 
microscopy and immunohistochemistry. The tumor was graded as low risk GIST. The opinion of a 
regional cancer society was sought; they did not recommend chemotherapy in view of the low grade of 
the tumor.  
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Discussion 
Small bowel diverticulum or diverticula per se is a rare disease, to conclude from the 
known actual incidence of symptomatic diverticulum. In many instances, diverticula may 
be incidentally diagnosed while performing a laparotomy for some other cause. There is a 
case report suggesting the occurrence of a small bowel diverticulum in 6 out of 8 
members of a family [1]. Large bowel diverticulum is more frequent when compared to 
small bowel diverticulum. Among small bowel diverticulum, false diverticulum is more 
common, which occurs at a weak point in the bowel wall towards the mesenteric border. 
True diverticulum (containing all 4 layers of the small bowel wall) is exceptionally rare 
and occurs at the antimesenteric border. Overall, the incidence of diverticulum reported 
is 0.06–1.3% [2]. Diverticulum is also known to be associated with diseases of 
immunological origin, such as rheumatoid arthritis, ulcerative colitis, and thyroiditis [1]. 
Symptoms in a diverticulum may be due to occurrence of bacterial overgrowth, 
inflammation, bleed, mechanical obstruction, or perforation. Rarely, patients may have 
malabsorption due to multiplicity of mesenteric diverticulum. Bleed in a diverticulum is 
usually due to inflammatory involvement of the arcade vessel but may rarely occur due to 
a mass lesion (as in our case) or a vascular malformation [3]. Tumors within a Meckel’s 
diverticulum are uncommon but recognized, with
 a reported incidence of 0.5–3.2% [4]. 
The case presented here is rare since it was a true diverticulum of the jejunum at the 
antimesenteric border and harbored a GIST. 
In the literature, in a series of 8 cases of small bowel diverticulum 7 were not diagnosed 
preoperatively [5]. Although the role of CT in the diagnosis of a diverticulum is 
underestimated, CT enteroclysis, if done with a 64-slice machine, can yield a more 
accurate diagnosis. As far as a gastrointestinal tumor occurring in a jejunal diverticulum 
is concerned, it may be the first of its kind in the literature. It is a well-known fact that 
GISTs are the most common connective tissue tumors of the GI tract, although they are 
overall rare in occurrence and an estimated incidence is 10–20 cases per million 
population per year [6]. Approximately 50–70% of GISTs originate in the stomach. The 
small intestine is the second most common location, with 20–30% of GISTs arising from 
the jejunoileum. Less frequent sites of occurrence include the colon and rectum (5–15%) 
and esophagus (<5%). The actual cell of origin of GISTs is a pluripotential mesenchymal 
stem cell programmed to differentiate into the interstitial cell of Cajal [7]. Gain-of-
function mutations in exon 11 of the c-kit proto-oncogene are associated with most 
GISTs. These mutations lead to constitutive overexpression and autophosphorylation of 
c-Kit, provoking a cascade of intracellular signaling that propels cells toward proliferation 
or away from apoptotic pathways. Surgery is the definitive therapy for patients with 
GISTs. Radical and complete surgical extirpation offers the only chance for cure. 
Debulking large lesions is helpful when adjuvant therapy with imatinib mesylate is 
considered. Imatinib mesylate (STI 571) is a selective tyrosine kinase inhibitor with action 
against mutant c-Kit and targets a specific molecular derangement. The role of imatinib 
in the management of advanced and perforated GISTs is a well established fact. All cases 
diagnosed to be GISTs need confirmation by immunostaining with CD114, 117 or CD 
134; this is the standard procedure accepted all over the world. Only tumors positive for 
immunostaining respond to treatment with the wonder drug imatinib mesylate. 
This particular case has been under follow-up for 9 months and has had no recurrence 
of symptoms or disease. Due to the tumor’s low malignant potential and a tumor size of 
<5 cm, chemotherapy with imatinib mesylate was not offered to this patient. 
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Fig. 1. CECT enterocalysis image showing a hyperdense vascular lesion in relation to the small bowel. 
 
 
 
Fig. 2. a, b Note the tumor in a diverticulum at the antimesentric border of the jejunal loop. 
 
 
 
Fig. 3. Resected specimen of the jejenum with tumor. 
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Fig. 4. Mucosal surface of the cut specimen showing a dimple-like opening representing the mouth of 
the diverticulum. 
 
 
 
Fig. 5. a–c Histopathological images of the tumor morphology showing predominantly spindle-shaped 
cells layed in sheats (a); note the uniform eosinophylic cells arranged in short fasicles on high-power 
evaluation and encircled areas mitotic cells per high-power field (b and c). 
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